Ucb Biopharma SPRL
Records under this name other than the patents Ucb Biopharma SPRL holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 80 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,784,823 | Binding Proteins, Including Antibodies, Antibody Derivatives and Antibody Fragments, That Specifically Bind CD154 and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,321,840 | Binding Proteins, Including Antibodies, Antibody Derivatives and Antibody Fragments, That Specifically Bind CD154 and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,338,592 | Fused thiazole derivatives as kinase inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,183,241 | 2-oxo-1-pyrrolidine derivatives Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,293,237 | Binding Proteins, Including Antibodies, Antibody Derivatives and Antibody Fragments, That Specifically Bind CD154 and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,729,653 | Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,427,650 | Dual specificity antibody fusions Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,275,777 | Process for Obtaining Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 11,384,136 | Process for Obtaining Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 12,091,450 | Antibodies of the class IGG4 Formerly held In force · From the USPTO record | In force | From the USPTO record |